The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits

T. J. Bergstrom, W. S. Wilkinson, G. L. Skuta, R. L. Watnick and V. M. Elner
Department of Ophthalmology, W. K. Kellogg Eye Center, Ann Arbor, MI 48105-1994.

A prospective, randomized, masked, placebo-controlled study was performed to determine whether a single, intraoperative subconjunctival application of a 0.5-mg/mL solution of mitomycin-C enhances the success of full-thickness filtration surgery in rabbits. Compared with control eyes, mitomycin-C-treated eyes showed significant increases in bleb duration from 8.1 +/- 2.4 to 68.0 +/- 20.8 days and in intraocular pressure reduction from 6.0 +/- 3.0 to 63.6 +/- 21.5 days. Histopathologic evaluation confirmed the inhibitory effects of mitomycin-C on fibrovascular, fibrocellular, and collagenous organization of the filtering blebs that resulted in their preservation. Transient, superficial, corneal vascularization anterior to the bleb occurred in all mitomycin-C-treated eyes. No other clinical or pathologic signs of undesirable side effects were noted. We studied the effectiveness and safety of a single intraoperative application of mitomycin-C in prolonging the success of filtration surgery in rabbits and its potential for similar use in humans.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mitomycin-C Induces the Apoptosis of Human Tenon's Capsule Fibroblast by Activation of c-Jun N-Terminal Kinase 1 and Caspase-3 Protease
Seong et al.
IOVS 2005;46:3545-3552.
ABSTRACT | FULL TEXT  

Mitomycin C-Induced Reduction of Keratocytes and Fibroblasts after Photorefractive Keratectomy
Kim et al.
IOVS 2004;45:2978-2984.
ABSTRACT | FULL TEXT  

Histopathological findings in filtering blebs with recurrent blebitis
Matsuo et al.
Br. J. Ophthalmol. 2002;86:827-827.
FULL TEXT  

Photodynamic Therapy to Control Fibrosis in Human Glaucomatous Eyes After Trabeculectomy: A Clinical Pilot Study
Diestelhorst and Grisanti
Arch Ophthalmol 2002;120:130-134.
ABSTRACT | FULL TEXT  

Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma
Manners et al.
Br. J. Ophthalmol. 2001;85:159-163.
ABSTRACT | FULL TEXT  

Inhibition of Conjunctival Scarring and Contraction by a Porous Collagen-Glycosaminoglycan Implant
Hsu et al.
IOVS 2000;41:2404-2411.
ABSTRACT | FULL TEXT  

Results of intraoperative mitomycin C application in dacryocystorhinostomy
Liao et al.
Br. J. Ophthalmol. 2000;84:903-906.
ABSTRACT | FULL TEXT  

Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery
Grisanti et al.
Br. J. Ophthalmol. 1999;83:1353-1359.
ABSTRACT | FULL TEXT  

Human Anti-Transforming Growth Factor-{beta}2 Antibody: A New Glaucoma Anti-Scarring Agent
Cordeiro et al.
IOVS 1999;40:2225-2234.
ABSTRACT | FULL TEXT  

New model of conjunctival scarring in the mouse eye
Reichel et al.
Br. J. Ophthalmol. 1998;82:1072-1077.
ABSTRACT | FULL TEXT  

Trabeculectomy augmented with mitomycin C application under the scleral flap
Beatty et al.
Br. J. Ophthalmol. 1998;82:397-403.
ABSTRACT | FULL TEXT  

Adjunctive use of mitomycin C on endoscopic lacrimal surgery
Anadolu and Aktürk
Br. J. Ophthalmol. 1998;82:63-66.
ABSTRACT | FULL TEXT  

Current approach to postoperative endophthalmitis
SUNARIC-MEGEVAND and POURNARAS
Br. J. Ophthalmol. 1997;81:1006-1015.
FULL TEXT